One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1093/annonc/mdz453
Copy DOI Journal: Annals of Oncology |  Publication Date: Dec 1, 2019 |
 Citations: 10 |  License type: publisher-specific-oa |
Affiliation: Gdańsk Medical University, European Institute of Oncology, Prince of Songkla University, Universidade Federal do Rio Grande, Pontifícia Universidade Católica do Rio Grande do Sul, Sarah Cannon, University of Limoges, Asklepios, Yale University, Vall d'Hebron Hospital Universitari, Istanbul University, Cornell University, University Hospital Medical Center Bezanijska kosa, Nagoya UniversityLBA1 Clinical efficacy of atezolizumab (atezo) in biomarker subgroups by SP142, SP263 and 22C3 PD-L1 immunohistochemistry (IHC) assays and by blood tumour mutational burden (bTMB): Results from the IMpower110 study
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
